ARCHIVES

CTEP Drafts FDA Approval Guidelines

This article is from The Cancer Letter archive.

Vol. 14 No. 10 | March 4, 1988

Download PDF Visit The Full Archive

Related Articles

The Future of Cancer Centers: Demographics Informatics, Genetics, Will BE Major Influences, Robert Young Says

May 7, 1999

NCI Renews City of Hope’s Comprehensive Cancer Center Designation.

May 30, 2008

Abstracts Of Papers Presented By Breast Cancer Task Force

September 17, 1976

Amgen Claimed QOL Benefit Despite FDA Label Change.

May 18, 2007

Phase 0 Trials Signal FDA’s New Reliance On Biomarkers For Drug Development.

January 13, 2006

Univ. Officials Propose Conflict Of Interest Guidelines In Report

April 13, 1990